Bilateral wilms tumor with TP53- Related anaplasia

Pediatric and Developmental Pathology

Volumn 16, Issue 3, 2013, Pages 217-223

  Popov, Sergey D ^a   Vujanic, Gordan M ^b   Sebire, Neil J ^c   Chagtai, Tasnim ^d   Williams, Richard ^d   Vaidya, Sucheta ^e   Pritchard Jones, Kathy ^c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Royal Marsden Foundation Trust   (United Kingdom)

Author keywords

Anaplasia; Bilateral; TP53; Wilms

Indexed keywords

CARBOPLATIN; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; PROTEIN P53; VINCRISTINE;

ANAPLASTIC CARCINOMA; APPETITE DISORDER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CHILD; COPY NUMBER VARIATION; EXON; FEMALE; FEVER; GANGLIONEUROMA; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRON; MALAISE; MALE; MOLECULAR GENETICS; NEPHRECTOMY; NEPHROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL NEPHRECTOMY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; SWELLING;

ANAPLASIA; CHILD, PRESCHOOL; FEMALE; GENE DOSAGE; GENES, P53; HUMANS; KIDNEY NEOPLASMS; MALE; MUTATION; POLYMERASE CHAIN REACTION; WILMS TUMOR;

EID: 84880060556     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/12-08-1245-CR.1     Document Type: Article

References (28)

1. Pritchard-Jones K. Nephrectomy-only for Wilms tumour: negotiating the tangled web requires multi-professional input. Pediatr Blood Cancer 2010;54:865-866.
2. Vujanic GM, Sandsted B, Harms D, et al. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol 2002;38:79-82. (Pubitemid 34113435)
3. Faria P, Beckwith JB, Mishra K, et al. Focal versus diffuse anaplasia in Wilms tumor-new definitions with prognostic significance. A report from the National Wilms Study Group. Am J Surg Pathol 1996;20:909-920. (Pubitemid 26250632)
4. Revesz T, Mpofu C, Fletcher S, et al. Progression to anaplasia in bilateral Wilms' tumor. Med Pediatr Oncol 1994;23:40-49. (Pubitemid 24166807)
5. Dome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms' tumor: results from the Fifth National Wilms' Tumor Study. J Clin Oncol 2006;24:2352-2358. (Pubitemid 46630667)
6. Bardeesy N, Falkoff D, Petruzzi MJ, et al. Anaplastic Wilms' tumor, a subtype displaying poor prognosis, harbours p53 gene mutation. Nat Genet 1994;7:91-97.
7. Coppes MJ, de Kraker J, van Dijken PJ, et al. Bilateral Wilms' tumor: long term survival and some epidemiological features. J Clin Oncol 1989;7:310-315. (Pubitemid 19075012)
8. Hamilton TE, Ritchey ML, Haase GM, et al. The management of synchronous bilateral Wilms tumor: A report from the National Wilms Tumor Study Group. Ann Surg 2011;253:1004-1010.
9. Ritchey M. Renal sparing surgery for children with bilateral Wilms tumor. Cancer 2008;112:1877-1878. (Pubitemid 351574062)
10. Abbaszadeh F, Barker KT, McCoville C, Scott R, Rahman N. A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma. Familial Cancer 2010;9:425-430.
11. Charles AK, Brown KW, Berry PJ. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development. Am J Pathol 1998;153:991-1000. (Pubitemid 28419052)
12. Breslow NE, Beckwith JB, Perlman EJ, Reeve AE. Age distribution, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer 2006;47:260-267. (Pubitemid 44148041)
13. Sebire NJ, Vujanic GM. Paediatric renal tumours: recent developments, new entities and pathological features. Histopathology 2009; 54:516-528.
14. Carli M, Frascella E, Tournade M, et al. Second malignant neoplasms in patients treated on SIOP Wilms Tumour Studies and Trials 1, 2, 5, and 6. Med Pediatr Oncol 1997;29:239-244. (Pubitemid 27329121)
15. Breslow NE, Takashima JR, Whitton JA, et al. Second malignant neoplasms following treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 1995;13:1851- 1859.
16. Shen Y, Troxel AB, Vedantam S, Penning TM, Field J. Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo+AFs-a+AF0- pyrene diol epoxide in vitro: role of reactive oxygen and biological selection. Chem Res Toxicol 2006; 19:1441-1450. (Pubitemid 44863486)
17. Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harbor Perspect Biol 2010;2:a001008.
18. Scursoni AM, Galluzzo L, Camarero S. Detection and characterization of N-glycosylated gangliosides in Wilms tumor by immunohistochemistry. Pediatr Dev Pathol 2010;13:18-23.
19. Jadali F, Sayadpour D, Rakhshan M, et al. Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor. Iran J Kidney Dis 2011;5:149-153.
20. Ghanem MA, van Steenbrugge GJ, Nijman RJM, van der Kwast TH. Prognostic markers in nephroblastoma (Wilms' tumor). Urology 2005;65:1047-1054. (Pubitemid 40824886)
21. Sredni ST, de Camargo B, Lopes LF, et al. Immunohistochemical detection of p53 protein expression as a prognostic indicator in Wilms tumor. Med Pediatr Oncol 2001;37:455-458. (Pubitemid 33029640)
22. Lahoti C, Thorner P, Malkin D, Yeger H. Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavourable outcome. Am J Pathol 1996;148:1577-1589. (Pubitemid 26135898)
23. Vujanic GM, Charles AK. Renal tumours of children: An update. Pathology 2008;40:217-227.
24. Hamilton TE, Green DM, Perlman EJ, et al. Bilateral Wilms' tumor with anaplasia: lesson from the national Wilms tumor study. J Pediatr Surg 2006;41:1642-1644.
25. Shamberger RC, Haase GM, Argani P, et al. Bilateral Wilms' tumors with progressive or nonresponsive disease. J Pediatr Surg 2006;41:653-657.
26. Williams RD, Al-Saadi R, Natrajan R, et al. Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor. Genes Chromosomes Cancer 2011;50:982-995.
27. Guertl B, Leuschner I, Harms D, Hoefler G. Genetic clonality is a feature unifying nephroblastomas regardless of the variety of morphological subtypes. Virch Arch 2006;449:171-174.
28. Moran C, Greiner R, Mardam-Bey SW, et al. Synchronous occurrence of metastatic Wilms tumor and ganglioneuroma. Pediatr Blood Cancer 2010;55:562-565.